News from NextGenNK 2021
- NextGenNK at Innate Killer Summit
- Interviews with experts in the NK cell and engager drug development field
- Four NextGenNK partners join forces in a phase II study in Multiple Myeloma
- Mini-symposium: Frontlines in NK cell cancer research and immunotherapy
- NextGenNK at Allogeneic Cell Therapies Summit 2021
- NextGenNK at Cell & Gene Therapy 2021
- Learn the basics of Advanced Therapy Medicinal Products (ATMPs)
- First Patient Included in Phase II Study in Multiple Myeloma
- Oncternal Therapeutics new part in NextGenNK